More tools:Markets·Screener·Research·Chat

CareDx, Inc. (CDNA) Financial Statements

CareDx, Inc.
SIC 8071 · SERVICES-MEDICAL LABORATORIES
FIGI BBG006JS5794
XNAS · usd
50.39▲ 0.08 (0.16%)
As of 2026-09-09
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close50.31
Day's Range49.46 – 50.87
52-Week Range13.12 – 53.67
Volume934.6K
Avg Volume1.2M
Share Statistics
Shares Outstanding
Employees765
ExchangeXNAS
Listed2014-07-17
Share count as of July 27, 2026
Loading Income Statement…
Key questions about CareDx, Inc. (CDNA)
What is CareDx, Inc.'s Market Cap?
CareDx, Inc.'s Market Cap is $2.6B, based on as-reported figures from SEC (XBRL) filings.
What is CareDx, Inc.'s Enterprise Value?
CareDx, Inc.'s Enterprise Value is $2.2B, based on as-reported figures from SEC (XBRL) filings.
What is CareDx, Inc.'s Trailing P/E?
CareDx, Inc.'s Trailing P/E is 23.5×, based on as-reported figures from SEC (XBRL) filings.
What is CareDx, Inc.'s Price / Sales?
CareDx, Inc.'s Price / Sales is 5.7×, based on as-reported figures from SEC (XBRL) filings.
What is CareDx, Inc.'s EV / Revenue?
CareDx, Inc.'s EV / Revenue is 4.9×, based on as-reported figures from SEC (XBRL) filings.
What is CareDx, Inc.'s EV / EBITDA?
CareDx, Inc.'s EV / EBITDA is 18.2×, based on as-reported figures from SEC (XBRL) filings.
What is CareDx, Inc.'s Revenue (TTM)?
CareDx, Inc.'s Revenue (TTM) is $458.1M, based on as-reported figures from SEC (XBRL) filings.
What is CareDx, Inc.'s Net Income (TTM)?
CareDx, Inc.'s Net Income (TTM) is $111.0M, based on as-reported figures from SEC (XBRL) filings.
What is CareDx, Inc.'s EBITDA?
CareDx, Inc.'s EBITDA is $122.5M, based on as-reported figures from SEC (XBRL) filings.
What is CareDx, Inc.'s Diluted EPS (TTM)?
CareDx, Inc.'s Diluted EPS (TTM) is 2.15, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue:
Total revenue
YoY growth+52.2%+39.0%+25.2%+20.7%
Operating expenses:
Research and development
Sales and marketing
General and administrative
Gain on sale of lab products business———
Litigation settlement expense
Total operating expenses
% of revenue14.2%99.0%105.6%100.2%
Income (loss) from operations
% of revenue85.8%1.0%-5.6%-0.2%
Other income:
Interest income, net
Other (expense) income, net
Total other income
Income (loss) before income taxes
Income tax (expense) benefit
Net income (loss)
% of revenue83.8%2.4%-3.8%1.7%
Basic (in usd per share)
Diluted (in usd per share)